Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)

This study is ongoing, but not recruiting participants.

Study NCT00046488 Information provided by Biogen Idec

First Received: September 30, 2002 Last Updated: July 10, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2010
Primary Completion Date:	April 2004 (Final data collection date for primary outcome measure)